Knoll Capital Management as of June 30, 2016
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 22 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 86.0 | $265M | 4.4M | 60.30 | |
| Corbus Pharmaceuticals Hldgs | 2.5 | $7.7M | 2.6M | 2.99 | |
| Synthetic Biologics | 2.2 | $6.7M | 3.7M | 1.80 | |
| Alcobra | 1.6 | $5.0M | 1.1M | 4.49 | |
| Ampio Pharmaceuticals | 1.4 | $4.2M | 3.2M | 1.29 | |
| Vascular Biogenics | 1.3 | $4.0M | 861k | 4.61 | |
| Abeona Therapeutics | 1.0 | $3.2M | 1.4M | 2.36 | |
| Cempra | 1.0 | $3.0M | 181k | 16.49 | |
| Advaxis | 0.7 | $2.2M | 275k | 8.09 | |
| Volitionrx (VNRX) | 0.5 | $1.5M | 462k | 3.15 | |
| Keryx Biopharmaceuticals | 0.4 | $1.3M | 200k | 6.62 | |
| Newlink Genetics Corporation | 0.4 | $1.2M | 102k | 11.26 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $773k | 136k | 5.69 | |
| Ohr Pharmaceutical | 0.2 | $562k | 205k | 2.74 | |
| Advaxis Inc. w exp 07/15/201 | 0.2 | $502k | 113k | 4.46 | |
| Bio Blast Pharma | 0.1 | $402k | 251k | 1.60 | |
| Evoke Pharma | 0.1 | $381k | 56k | 6.85 | |
| Caladrius Biosciences | 0.1 | $328k | 556k | 0.59 | |
| Champions Oncology (CSBR) | 0.1 | $239k | 111k | 2.15 | |
| Galmed Pharmaceuticals | 0.1 | $224k | 50k | 4.48 | |
| Aptose Biosciences | 0.0 | $29k | 12k | 2.43 | |
| Zosano Pharma | 0.0 | $15k | 11k | 1.34 |
